Encompass Health price to book ratio EHC
Market value divided by the book value of the company's net assets, since 2011.
- Today, Oct 23, 2026
- 4.7×
- 10-year median
- 4.2×
- Against its 10-year history
- 75th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 2.3× to 5.7×
- Peer median
- 5.8×
Encompass Health's price to book ratio is 4.7× as of Oct 23, 2026.
That is above its ten-year median of 4.2×, higher than on 75% of days in the last ten years.
Over that time it ranged from 2.3× in Sep 2022 to 5.7× in Jun 2025.
The median for 10 hospital and care facility stocks of a similar size is 5.8×.
Price to book ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 4.7× | 3.9× | 4.9× |
| 2025 | 4.6× | 4.5× | 5.7× |
| 2024 | 4.8× | 4.4× | 5.4× |
| 2023 | 4.3× | 3.9× | 5.2× |
| 2022 | 4.9× | 2.3× | 4.9× |
| 2021 | 2.8× | 2.5× | 4.5× |
| 2020 | 4.3× | 2.9× | 4.9× |
| 2019 | 4.1× | 3.5× | 4.2× |
| 2018 | 3.7× | 3.5× | 5.1× |
| 2017 | 3.4× | 3.0× | 4.5× |
| 2016 | 4.1× | 3.6× | 4.7× |
| 2015 | 4.0× | 3.9× | 7.0× |
| 2014 | 6.2× | 5.8× | 7.4× |
| 2013 | 7.2× | 6.4× | 21.2× |
| 2012 | 6.4× | 6.4× | 14.6× |
| 2011 | 8.8× | 8.0× | 29.3× |
Against its peers
Companies in Medical - Care Facilities nearest Encompass Health's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| EHCEncompass Health | 4.7× |
| BTSGBrightSpring Health Services | 5.8× |
| DVADavita | n/m |
| UHSUniversal Health Services | 1.5× |
| ENSGEnsign | 4.2× |
| PACSPACS | 6.8× |
| THCTenet Healthcare | 4.6× |
| CHEChemed | 8.1× |
| SHCSotera Health | 7.8× |
| CONConcentra Group Holdings Parent | 10.5× |
| LFSTLifeStance Health | 3.3× |
| Peer median | 5.8× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Encompass Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.